Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
Atara Biotherapeutics
ATRA
$76.9M
| $158K | ﹤0.01% |
347
-290
| -46% | -$107K |
|
|
BGFV
4802
DELISTED
Big 5 Sporting Goods
BGFV
| $158K | ﹤0.01% |
20,726
-18,656
| -47% | -$134K |
|
4803
CTS Corp
CTS
$1.91B
| $158K | ﹤0.01% |
6,152
+5,212
| +554% | +$137K |
|
4804
CALL
iShares Russell 3000 ETF
IWV
$20.2B
| $158K | ﹤0.01% |
1,000
+900
| +900% | +$139K |
|
|
ADAM
4805
Adamas Trust
ADAM
$848M
| $158K | ﹤0.01% |
6,442
-21,142
| -77% | -$531K |
|
|
GWPH
4806
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $158K | ﹤0.01% |
+1,200
| New | +$141K |
|
4807
Cytokinetics
CYTK
$10.7B
| $157K | ﹤0.01% |
19,297
+3,794
| +24% | +$43.1K |
|
4808
PUT
Dell
DELL
$299B
| $157K | ﹤0.01% |
6,898
| – | – |
|
4809
MacroGenics
MGNX
$248M
| $157K | ﹤0.01% |
8,282
+7,253
| +705% | +$135K |
|
|
DISCK
4810
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $157K | ﹤0.01% |
+7,400
| New | +$136K |
|
|
AKAO
4811
DELISTED
Achaogen Inc
AKAO
| $157K | ﹤0.01% |
14,593
-16,809
| -54% | -$211K |
|
|
TCF
4812
DELISTED
TCF Financial Corporation
TCF
| $157K | ﹤0.01% |
7,620
-18,292
| -71% | -$342K |
|
4813
Telefônica Brasil
VIV
$19.5B
| $156K | ﹤0.01% |
10,550
+10,549
| +1,054,900% | +$162K |
|
|
ENZ
4814
DELISTED
Enzo Biochem, Inc.
ENZ
| $156K | ﹤0.01% |
19,129
+972
| +5% | +$9.28K |
|
|
CRAY
4815
DELISTED
Cray, Inc.
CRAY
| $156K | ﹤0.01% |
6,439
+5,433
| +540% | +$115K |
|
|
ICON
4816
DELISTED
Iconix Brand Group, Inc.
ICON
| $156K | ﹤0.01% |
12,123
+11,547
| +2,005% | +$327K |
|
4817
PUT
Ternium
TX
$10.5B
| $155K | ﹤0.01% |
4,900
+3,300
| +206% | +$98.8K |
|
4818
BOK Financial
BOKF
$8.78B
| $154K | ﹤0.01% |
1,667
+1,307
| +363% | +$115K |
|
4819
Turning Point Brands
TPB
$1.62B
| $154K | ﹤0.01% |
7,301
+400
| +6% | +$7.05K |
|
|
FPRX
4820
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $154K | ﹤0.01% |
7,033
-3,082
| -30% | -$99.1K |
|
|
HOS
4821
PUT
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $154K | ﹤0.01% |
49,400
+33,200
| +205% | +$121K |
|
|
ALDR
4822
DELISTED
Alder Biopharmaceuticals
ALDR
| $154K | ﹤0.01% |
13,407
-135,249
| -91% | -$1.51M |
|
4823
ProShares Ultra Silver
AGQ
$1.29B
| $153K | ﹤0.01% |
4,524
+4,343
| +2,399% | +$144K |
|
4824
ATN International
ATNI
$369M
| $153K | ﹤0.01% |
2,769
-1,845
| -40% | -$101K |
|
4825
PUT
Penske Automotive Group
PAG
$14.2B
| $153K | ﹤0.01% |
3,200
-2,700
| -46% | -$127K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.